Novel bacterial therapy approach for treating lung cancer Isra Zaman27 Dec 2022 9:00 AM ISTColumbia Engineering researchers report thatthey have developed a preclinical evaluation pipeline for characterization ofbacterial therapies in lung...
Nebulized ensifentrine significantly improves lung function and reduces COPD exacerbations: Phase 3 trial results Dr. Kamal Kant Kohli26 Dec 2022 9:45 AM ISTUSA: Nebulization with ensifentrine significantly improved lung function and reduced the risk and rate of COPD (chronic obstructive pulmonary disease)...
High-flow oxygen therapy not superior to NIV/ LFOT as rescue therapy in kids Jacinthlyn Sylvia26 Dec 2022 9:00 AM ISTA new study published in Pediatric Critical Care Medicine suggests that high-flow oxygen therapy does not appear to be superior to low-flow oxygen...
Cystic fibrosis drug helpful for pneumonia treatment, study finds Dr. Kamal Kant Kohli24 Dec 2022 11:00 AM ISTGermany: The researchers from Berlin have discovered a potential new therapy in the form of a cystic fibrosis drug that proved effective in their...
Smoking heightens the likelihood of having mid-life memory loss, confusion, finds study Isra Zaman24 Dec 2022 9:45 AM ISTThe self-reported experience of greater or more frequent confusion or memory loss is known as subjective cognitive decline (SCD). One of the first...
24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin bests standard-care treatment for rifampin-resistant tuberculosis Medha Baranwal22 Dec 2022 8:00 AM ISTStandard-care treatment was similarly efficacious when patients could receive it without adverse effects, according to findings from a two-stage,...
PET/CT imaging reveals risk of major adverse cardiovascular events in pneumonia patients: Study Medha Baranwal21 Dec 2022 8:00 PM ISTCanada: FDG-PET/CT scans have revealed that vascular inflammation may trigger high rates of adverse events and heart attacks in pneumonia patients,...
Novel drug delivered through nasal spray promising treatment for sleep apnea Dr. Kamal Kant Kohli20 Dec 2022 8:00 PM ISTAustralia: A novel, potent, TASK 1/3 channel antagonist, BAY2586116, in development for obstructive sleep apnoea (OSA), has yielded positive results...
FDA approval to targeted imaging agent pafolacianine for use in lung cancer surgery Isra Zaman20 Dec 2022 10:00 AM ISTMore than 130,000 Americans die of lung cancer each year, making lung cancer the leading cause of cancer mortality in the country. Lung cancer...
Bivalent mRNA booster vaccine reduces risk of severe COVID-19 by more than half: CDC Medha Baranwal20 Dec 2022 9:45 AM ISTUSA: Updated bivalent (two-strain) mRNA booster shots reduce the risk of contracting severe COVID-19 by up to 57%, a recent study in Morbidity and...
FDA approves "glowing tumor" imaging agent Cytalux to aid lung cancer surgery Dr. Kamal Kant Kohli20 Dec 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This...
Opioid analgesia may reduce efficacy of immune checkpoint inhibitors among advanced lung cancer patients Dr. Shravani Dali19 Dec 2022 9:30 AM ISTOpioid analgesia may reduce the efficacy of immune checkpoint inhibitors suggests a recent study published in the BMC Pulmonology medicine. A...
